Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues Kyivstar Group Ltd KYIV Q1 2026 Earnings EPS Surprises to the Upside Stock Rallies FHN Q1 2026 Earnings EPS Beats Estimates as Capital Strength Shines FENG Q3 2024 Earnings Net Loss Deepens as Advertising Headwinds Persist Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues NCDL Q1 2026 Earnings Earnings Miss Estimates as Portfolio Pressures Emerge